Research Site 229 — Palm Springs, California

Research Site 229 is a clinical research site located in Palm Springs, California, United States 92262.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site 229 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypertriglyceridemia.

Sponsors: Arrowhead Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palm Springs

Browse all research sites in California · View every site in Palm Springs

• Desert Hospital Comprehensive Cancer Center
• Desert Regional Medical Center
• Palmtree Clinical Research
• Research Site
• GSK Investigational Site
• Desert Oasis Healthcare Medical Group
• Desert Oasis Hlthcr Med Group
• Desert Regional Medical Center Comprehensive Cancer Center
• Novo Nordisk Investigational Site
• Comprehensive Cancer Center
• Pfizer Investigational Site
• Southern California Desert Retina Consultants, MC

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 229?

Research Site 229 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 229 conducted?

Research Site 229 has 1 clinical trials on record, with 1 currently active. Their work covers Hypertriglyceridemia.

Is Research Site 229 accredited by Crixeo Clinical Trials?

Research Site 229 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 229?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.